Lillian Swiersz
Reproductive Endocrinology · Palo Alto, CANPI 1528134566
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 103 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by AbbVie at 29.9% of the total. Reporting peaked in 2022 at $582 and has fallen 54.4% since, to $265 in 2025.
Across 103 payments — averaging $20.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$635
- Mayne Pharma Commercial LLC$174
- Cranial Technologies, Inc$144
- Hologic Sales And Service, LLC$123
- Sumitomo Pharma America, Inc.$115
- Kaleo, Inc.$111
- plus $821 from 24 others
What the payments were for
- Food & beverage$2,123100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 29 | $635 |
| Mayne Pharma Commercial LLC | 9 | $174 |
| Cranial Technologies, Inc | 9 | $144 |
| Hologic Sales And Service, LLC | 6 | $123 |
| Sumitomo Pharma America, Inc. | 5 | $115 |
| Kaleo, Inc. | 5 | $111 |
| Myovant Sciences Inc. | 4 | $87 |
| Evofem Biosciences, Inc. | 4 | $79 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $72 |
| Ferring Pharmaceuticals Inc. | 3 | $71 |
| Lilly USA, LLC | 3 | $67 |
| Merck | 3 | $55 |
| Roche Diagnostics Corporation | 2 | $41 |
| Coloplast | 2 | $33 |
| Astellas Pharma US Inc | 1 | $30 |
| BD | 1 | $23 |
| Bayer | 1 | $23 |
| Urovant Sciences Inc | 1 | $23 |
| Novo Nordisk | 1 | $22 |
| Coopersurgical, Inc. | 1 | $21 |
| Avion Pharmaceuticals | 1 | $20 |
| Aspira Women's Health Inc | 1 | $20 |
| Bausch Health US, LLC | 1 | $20 |
| Exeltis, USA Inc. | 1 | $18 |
| Alk-abello, Inc | 1 | $17 |
| Agiliti Surgical, Inc. | 1 | $16 |
| Axonics, Inc. | 1 | $16 |
| Channel Medsystems, Inc. | 1 | $16 |
| Sage Therapeutics, LLC | 1 | $15 |
| Olympus America Inc. | 1 | $14 |
How this compares
$2,123 in reported general payments places this provider in the 75th percentile of 230 reproductive endocrinology providers in California.
See all reproductive endocrinology providers in California →
Other reproductive endocrinology in Palo Alto
- Ruben AlveroPalo Alto$11K
- Salli TazukePalo Alto$8K
- Lusine AghajanovaPalo Alto$7K
- Ruth LathiPalo Alto$3K
- Sharon WinerBeverly Hills$449K
- Sanjay Agarwalla Jolla$262K
- Valerie FloresSan Diego$184K
- Monica PasternakSan Francisco$77K
- Linda GiudiceSan Francisco$67K
- Valerie BakerSan Jose$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.